Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lesho

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Jac-Antimicrobial Resistance|December 15, 2021
A panel of diverse <i>Pseudomonas aeruginosa</i> clinical isolates for research and developmentFrancois Lebreton, Erik Snesrud, Lindsey Hall, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivityNicholas S Geraci, Rami M Mukbel, Michael T Kemp, et al.
Med (New York, N.Y.)|August 10, 2023
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case seriesHadil Onallah, Ronen Hazan, Ran Nir-Paz, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Jac-Antimicrobial Resistance|December 15, 2021
A panel of diverse <i>Pseudomonas aeruginosa</i> clinical isolates for research and developmentFrancois Lebreton, Erik Snesrud, Lindsey Hall, et al.
The American Journal of Tropical Medicine and Hygiene|March 12, 2014
Profiling of human acquired immunity against the salivary proteins of Phlebotomus papatasi reveals clusters of differential immunoreactivityNicholas S Geraci, Rami M Mukbel, Michael T Kemp, et al.
Med (New York, N.Y.)|August 10, 2023
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case seriesHadil Onallah, Ronen Hazan, Ran Nir-Paz, et al.
Pageof 7